Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004580384 | SCV005064388 | pathogenic | Gorlin syndrome; Medulloblastoma | 2023-10-15 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the SUFU gene has been identified. Loss-of-function variants in SUFU are known to be pathogenic (PMID: 22508808, 25403219, 33024317). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. Isolated whole-gene deletions of SUFU have not been reported in the literature. However, larger copy number events that include this gene have been reported (PMID: 12068298, 31639285). For these reasons, this variant has been classified as Pathogenic. |